IMMUNIC, INC. (IMUX) Form 8-K — Jul 6, 2026
Director Tamar Howson resigned from the Immunic, Inc. Board and Compensation Committee effective June 29, 2026, due to retirement. The Company confirmed the departure was not the result of any disagreement regarding operations, policies, or practices. Erik Lundgren, the Company's Chief Executive Officer, was appointed as a Class II director on July 5, 2026, filling the vacancy.
Price after filing
1 day: +3.4%7 days: -1.5%30 days: -5.5%
Close on the filing date to close N calendar days later (from $14.86). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.